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Background: Specific immunoglobulin E (IgE) sensitization to staphylococcal enterotoxin (SE) has been recently 
considered to be related to allergic disease, including asthma. Despite studies on specific IgE (sIgE) to SE and its 
relationship to asthma diagnosis and severity, the association of sIgE to SE with airway hyperresponsiveness (AHR) 
remains unclear.
Methods: We enrolled 81 asthma patients admitted to the Severance Hospital in Korea from March 1, 2013, to February 28, 
2015 and retrospectively reviewed the electronic medical records of the enrolled subjects. The serum levels of sIgE to SE (A/
B) of all subjects was measured using the ImmunoCAP 250 (Phadia) system with SE-sIgE positive defined as >0.10 kU/mL.
Results: The SE-sIgE level was not significantly correlated with asthma severity (forced expiratory volume in 1 second 
[FEV1], FEV1/forced vital capacity, sputum eosinophils, and serum eosinophils), whereas the SE-sIgE level in patients 
with positive AHR (mean±standard error of the mean, 0.606±0.273 kU/mL) was significantly higher than that in patients 
with negative AHR (0.062±0.015 kU/mL, p=0.034). In regression analysis, SE sensitization (sIgE to SE ≥0.010 kU/mL) 
was a significant risk factor for AHR, after adjustment for age, sex, FEV1, and sputum eosinophils (odds ratio, 7.090; 95% 
confidence interval, 1.180–42.600; p=0.032). Prevalence of SE sensitization was higher in patients with allergic rhinitis and 
non-atopic asthma patients, as compared to patients without allergic rhinitis and atopic asthma patients, respectively, 
but without statistical significance.
Conclusion: SE sensitization is significantly associated with AHR.
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Introduction
Staphylococcus aureus is a human commensal microor-
ganism, and frequent colonizer of airways and skin. S. aureus 
releases a wide range of enterotoxins1. While bacterial infec-
tion commonly stimulates the innate immune system, staphy-
lococcal enterotoxin (SE) can act as an antigen, in particular, 
a superantigen2. SE binds to the variable β-chain of the T-cell 
receptor, independent of the antigen-specific groove, so that it 
is called a “superantigen.” This allows the polyclonal activation 
of T cells and also B cells, resulting in the formation of specific 
immunoglobulin E (sIgE) to SE, called “SE sensitization”2-4. 
These superantigenic properties of SE are considered to have 
a role in the pathophysiology of allergic disease.
The first allergic disease to be studied for association with 
SE was atopic dermatitis5. Since then, evidence has been gath-
ered that SE also has an important role in upper and lower 
airway disease1,2,6. The bacterial allergy, sensitization to SE, is 
considered to be more important than bacterial infection as a 
cause and aggravating factor for allergic airway disease7. Re-
cent studies have revealed that SE sensitization is an indepen-
dent risk factor for asthma and, especially, the severe asthma 
entity4,8-10. In severe asthmatics, inability to cope with S. aureus 
colonization in airways by impaired macrophages leads to 
impairment of mucosal immunity and sensitization to SE11. 
Asthma represents an inflammatory airway disease with fea-
tures of mucosal edema and mucus secretion, after allergen 
stimulation. Airway hyperresponsiveness (AHR), which is 
measured as increased airway resistance following provoca-
tion with stimuli, reflects impairment of mucosal immunity 
and might be associated with SE sensitization. However, the 
correlation of SE sensitization with AHR in common asthma 
patients has never been researched in human clinical studies.
We aimed to evaluate the correlation of SE sensitization 
with asthma severity, especially AHR, in asthma patients.
Materials and Methods
1. Study population
We retrospectively enrolled 81 asthma patients whose sIgE 
to SE data were available and admitted to the Severance Hos-
pital in Korea from March 1, 2013, to February 28, 2015. We 
retrospectively reviewed the electronic medical records of the 
enrolled subjects. Asthma was diagnosed by an allergy spe-
cialist, based on clinical guidelines, using a bronchodilator test 
and/or bronchial provocation test12. This study was approved 
by the Institutional Review Board of Yonsei University College 
of Medicine (approval number: 4-2013-0397). All enrolled pa-
tients provided written informed consent.
2. Laboratory tests
The complete blood count test was performed using an 
automated analyzer to determine blood eosinophil counts. 
The eosinophil percentages in induced sputum were assessed 
as follows. The obtained sputum was centrifuged, and the su-
pernatant was collected. Samples were diluted in phosphate-
buffered saline and centrifuged at 450 rpm for 6 minutes to 
prepare cytology slides. After staining the slides with Wright’s 
stain, a differential count was performed using a light micro-
scope, as reported previously13. Forced expiratory volume in 
1 second (FEV1) and FEV1/forced vital capacity (FVC) were 
evaluated by pulmonary function test using commercially 
available equipment (MS-IOS, Masterlab-IOS; Jaeger, Wurz-
burg, Germany). AHR was assessed by methacholine chal-
lenge test or mannitol challenge test, using a titration protocol 
as in previous reports. The methacholine challenge started 
with an inhalation of saline, followed by increasing the con-
centration of methacholine serially, up to a maximum concen-
tration of 25 mg/mL. We defined positive as the provocative 
concentration of methacholine required to decrease FEV1 by 
20% (PC20), being achieved at less than or equal to 25 mg/mL. 
The mannitol challenge test ended when a cumulative dose 
of 635 mg had been inhaled. We defined positive as PD15, the 
provocative concentration of mannitol required to decrease 
FEV1 by 15%, less than or equal to 635 mg. All of these tests 
were conducted before chart review. We retrospectively re-
viewed the results of the tests. 
3. Clinical parameters
Allergic rhinitis was clinically diagnosed, based on interna-
tional guidelines which recommend identifying symptoms, 
including sneezing, rhinorrhea, nasal obstruction, and itching 
with specific IgE possession confirmed by skin prick test or 
ImmunoCAP 250 (Phadia, Uppsala, Sweden) system14. Atopy 
was defined as positive response to any one of the inhalant al-
lergens (birch, oak, ragweed, mugwort, cat dander, house dust 
mite, etc.) by ImmunoCAP 250 (Phadia) system, as previously 
described15. 
4. Serum preparation and measurement of sIgE to SE
We measured the levels of sIgE to SE (A/B) in all subjects. 
First, whole blood was collected in a vacuum tube for serum 
separation. Serum was separated by centrifugation, and al-
lergen sIgE detection performed using ImmunoCAP 250 
(Phadia) system. The system was operated according to the 
manufacturer’s instructions. The sIgE to SE detection range 
was 0.1 to 100 kU/L. 
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5. Statistical analysis
We assessed correlation between two continuous variables 
using Pearson’s test. The t test was used to compare levels of 
sIgE to SE according to AHR. We selected, as the parameters, 
sex and age, which are most commonly among the variables 
considered, and FEV1 and sputum eosinophil count, which 
are known to be highly related to asthma severity. We deter-
mined the odds ratio (OR) using logistic regression analysis, 
including univariate and multivariate analysis. Cross-correla-
tion analysis was performed using chi-square tests to analyze 
the correlation between categorized variables in SPSS version 
18.0 (SPSS Inc., Chicago, IL, USA). We considered a p<0.05 to 
be significant. 
Results
1. Demographics of subjects
We enrolled a total of 81 asthma patients. The mean age of 
subjects and the standard deviation from the mean was 56.1 
years old. The mean value of sIgE to SE and the standard de-
viation from the mean was 0.260 kU/mL. The FEV1 and FEV1/
FVC were assessed by pulmonary function tests and repre-
sented a mildly obstructive pattern. The percentage of sputum 
eosinophils and the standard deviation was elevated beyond 
the normal range. There was a predominance of females. The 
prevalence of allergic rhinitis and atopy was 75.3% and 59.5%, 
respectively. Airway hyperresponsiveness was evaluated in 
44 patients, and the results were positive in 45.5%. We defined 
positive to SE-sIgE as more than 0.10 kU/mL, so that the posi-
tivity rate is about 40% (39.5% exactly) (Table 1). 
2. Correlation of sIgE to SE with parameters associated 
with asthma
We evaluated the correlation of SE-sIgE with parameters 
Table 1. Demographics of subjects
Parameter Value
Age, yr 56.1±15.9
sIgE to SE, kU/mL 0.260±0.701
Parameters associated with asthma
    FEV1, % 76.3±22.1
    FEV1/FVC, % 75.1±11.5
    Serum eosinophil, % 349.4±315.7
    Sputum eosinophil, % 15.2±18.0
Sex
    Male 22 (27.2)
    Female 59 (72.8)
Allergic rhinitis
    Without 20 (24.7)
    With 61 (75.3)
Atopy
    Negative 15 (40.5)
    Positive 22 (59.5)
Airway hyperresponsiveness
    Negative 24 (54.5)
    Positive 20 (45.5)
sIgE to SE (categorized), kU/mL
    <0.10 49 (60.5)
    ≥0.10 32 (39.5)
Total 81 (100)
Values are presented as mean±standard deviation or number (%).
sIgE: specific immunoglobulin E; SE: staphylococcal enterotoxin; 
FEV1: forced expiratory volume in 1 second; FVC: forced vital 
capacity.
Table 2. Correlation of sIgE to SE with parameters associated 
with asthma
Parameter Pearson’s coefficient p-value
FEV1 0.099 0.385
FEV1/FVC 0.149 0.206
Serum eosinophil, % 0.091 0.417
Sputum eosinophil, % 0.027 0.815
sIgE: specific immunoglobulin E; SE: staphylococcal enterotoxin; 
FEV1: forced expiratory volume in 1 second; FVC: forced vital 
capacity.
Figure 1. Comparison of specific immunoglobulin E (sIgE) to 
staphylococcal enterotoxin (SE) levels according to airway hyper-
responsiveness (AHR) (p=0.034). *p-value<0.05 obtained by t-test.
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representing asthma severity. The FEV1 (%) and FEV1/FVC 
(%) were not significantly correlated with the levels of SE-sIgE 
(p=0.385 and p=0.206, respectively). The serum eosinophils 
(%) and sputum eosinophil (%) were also not significantly 
associated with the levels of SE-sIgE (p=0.417 and p=0.815, 
respectively) (Table 2). 
3. Comparison of sIgE to SE levels according to AHR
We compared the levels of sIgE to SE according to AHR 
as assessed by the mannitol challenge test or methacholine 
challenge test. The sIgE to SE levels in patients with positive 
AHR (sample size, 20; mean±standard error of the mean, 
0.606±0.273 kU/mL) was significantly higher than that in pa-
tients with negative AHR (sample size, 24; 0.062±0.015 kU/
mL; p=0.034) (Figure 1).
4. Univariate and multivariate analysis for airway 
hyperresponsiveness
We aimed to identify which parameters could be significant 
predictive factors for AHR, as assessed by logistic regression. 
Using univariate analysis, sex (OR, 1.500; 95% confidence 
interval [CI], 0.400–5.620; p=0.547) and age (OR, 0.714; 95% 
CI, 0.202–2.528; p=0.602) were not significant predictive fac-
tors. The increase in FEV1 (%), indicating better lung function 
status, was a significant preventive factor (OR, 0.955; 95% CI, 
0.914–0.998; p=0.041). The increase in sputum eosinophils 
(%), sputum eosinophilia, was a significant risk factor (OR, 
1.047; 95% CI, 1.009–1.087; p=0.015). Being positive for sensi-
tization to SE (≥0.010 kU/mL) was not statistically significant 
risk factor for AHR (OR, 2.455; 95% CI, 0.685–8.798; p=0.168). 
Using multivariate analysis, to control for the other factors, 
being female was a significant risk factor for AHR (OR, 8.908; 
95% CI, 1.009–78.624; p=0.049). The increase in FEV1, which 
univariate analysis showed to be significant, was not a signifi-
cant protective factor after adjustment for the other variables 
(OR, 0.955; 95% CI, 0.906–1.006; p=0.084). The percentage of 
sputum eosinophils was an independent risk factor for AHR 
(OR, 1.059; 95% CI, 1.007–1.114; p=0.025). Although positive 
sensitization to SE was not a significant risk factor when the 
other factors were not taken into account, it was a significant 
risk factor for AHR (OR, 7.090; 95% CI, 1.180–42.600; p=0.032) 
after adjusting for age, sex, FEV1, and sputum eosinophils 
(Table 3).
When we adjust the cut-off value to 0.014 kU/mL to define 
30% of patients as positive to SE sensitization, SE sensitization 
was a significant risk factor without adjustment (OR, 4.667; 
95% CI, 1.037–21.010; p=0.045) and also with adjustment (OR, 
14.096; 95% CI, 1.823–108.970; p=0.011).
5. Prevalence of positive to sIgE to SE according to 
allergic rhinitis and atopy
We assessed whether the prevalence of positive sensitiza-
tion to SE will be different according to the presence of allergic 
rhinitis and atopy or not. The positive sensitization rate to 
Table 3. Univariate and multivariate analysis for AHR of data from 44 patients
Parameter
No. of patients 
(%)
Univariate effect estimate Multivariate effect estimate
Crude OR (95% CI) p-value Adjusted OR (95% CI) p-value
Sex
    Male 22 (27.2) Reference Reference
    Female 59 (72.8) 1.500 (0.400–5.620) 0.547 8.908 (1.009–78.624) 0.049*
Age, yr
    <65 55 (67.9) Reference Reference
    ≥65 26 (32.1) 0.714 (0.202–2.528) 0.602 1.678 (0.304–9.249) 1.678
Asthma associated parameters
    FEV1, % 0.955 (0.914–0.998) 0.041* 0.955 (0.906–1.006) 0.084
    Sputum eosinophil, % 1.047 (1.009–1.087) 0.015* 1.059 (1.007–1.114) 0.025*
sIgE to SE, kU/mL 
    <0.010 57 (70.4) Reference Reference
    ≥0.010 24 (29.6) 2.455 (0.685–8.798) 0.168 7.090 (1.180–42.600) 0.032*
p-value was obtained by logistic regression.
*Significant value.
AHR: airway hyperresponsiveness; OR: odds ratio; CI: confidence interval; FEV1: forced expiratory volume in 1 second; sIgE: specific 
immunoglobulin E; SE: staphylococcal enterotoxin.
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SE in patients without allergic rhinitis was 30.0%, and that in 
patients with allergic rhinitis was 42.6% without statistically 
significant difference (p=0.431). The positive sensitization rate 
to SE in non-atopic asthma patients was 40.0%, whereas that 
in atopic asthma patients was 31.8% (p=0.730) (Table 4).
Discussion
The novel finding of this study is that SE sensitization might 
be significantly associated with AHR. Although some research-
ers have shown the correlation of SE sensitization with asthma 
diagnosis and severity, effects of SE sensitization on AHR have 
not been well studied. An allergen-provocation test is a clear-
cut way to prove the allergen causes the allergic disease. The 
direct cause of asthma can be proven by AHR induced by spe-
cific allergens. Although the result presented in this study was 
not a measure of AHR with SE challenge, we revealed that SE 
sensitization is significantly associated with AHR. This finding, 
when considered against the significant correlation between 
SE sensitization and asthma diagnosis and severity described 
in the literature, more pointedly supports the hypothesis that 
SE sensitization might lead to asthma.
Actually, study of asthma in the mouse model has already 
shown that AHR was able to be induced following SE sensi-
tization16,17. These studies have explained the mechanism by 
which SE sensitization induces AHR as follows. SE acts as a 
superantigen to activate T cells independent of the peptide-
binding groove area. SE induces airway inflammation, char-
acterized by increased numbers of lymphocytes and eosino-
phils and by increased levels of the Th2 cytokine, interleukin 
4, together with marked upregulation of tumor necrosis factor 
α production by macrophages. This inflammatory response 
may lead to AHR.
Although AHR was assessed in only 44 patients, we found 
that SE sensitization is significantly associated for AHR. We 
used a cut-off value of positive sensitization, 0.010 kU/mL, 
which is widely used in analogous studies8,18,19. When we ad-
just the cut-off value to 0.014 kU/mL, SE sensitization showed 
more significant power. SE sensitization might be shown to be 
a significant independent risk factor for AHR, when a larger 
number of subjects is examined. 
Previous studies revealed that the SE positivity rate is higher 
in severe asthma than in control and non-severe asthma, but 
this is still controversial4,19-22. Rossi and Monesterolo22 reported 
the significant correlation of SE sensitization with serum eo-
sinophil cationic protein levels, indicating that SE sensitiza-
tion might be correlated with asthma severity. Kowalski et 
al.19 found that SE sensitization is significantly correlated with 
lung function parameters, following adjustment for age. Song 
et al.10 indicated that SE sensitization may be correlated with 
sputum eosinophilia. However, the present study could not 
demonstrate a significant correlation of SE sensitization with 
asthma parameters, including sputum eosinophilia. We found 
SE sensitization is significantly correlated with AHR, regard-
less of asthma parameters. SE sensitization might be more as-
sociated with AHR rather than other asthma parameters, such 
as lung function and eosinophilia. 
We found that SE sensitization was frequently observed in 
patients with allergic rhinitis (42.6%) compared to patients 
without (30.0%), but without statistical significance. The fail-
ure of this result to reach statistical significance might be due 
to the small number of subjects studied. Further study with 
larger sample of allergic rhinitis patients should be performed 
to evaluate whether SE sensitization is frequently observed in 
patients with allergic rhinitis rather than patients without. 
We also found that the prevalence of SE sensitization was 
lower in patients with atopic asthma, but without statistical 
significance. This unresolved association also might yield 
statistically significant results, were more subjects enrolled. In 
contrast to atopic asthma, non-atopic asthma is usually asso-
ciated with elderly age, non-eosinophilic asthma, and severe 
refractory asthma. Song et al.10 previously described a positive 
correlation of SE sensitization rate with aging, positive correla-
Table 4. Prevalence of positive to sIgE to SE according to allergic rhinitis and atopy
sIgE to SE
Total p-value*
<0.10 kU/mL ≥0.10 kU/mL
Allergic rhinitis
    Without 14 (70.0) 6 (30.0) 20 (100)
    With 35 (57.4) 26 (42.6) 61 (100) 0.431
Atopy
    Negative 9 (60.0) 6 (40.0) 15 (100)
    Positive 15 (68.2) 7 (31.8) 22 (100) 0.730
Values are presented as number (%).
*p-value was obtained by chi-square test.
sIgE: specific immunoglobulin E; SE: staphylococcal enterotoxin.
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tion of total IgE with SE sensitization, and inverse correlation 
of SE sensitization with atopic status9. Our results concerning 
the inverse correlation of SE sensitization with atopic status 
are concordant with the previous study described by Song et 
al.10 Although data are not shown, highly significant correla-
tion between total IgE with SE sensitization (Pearson’s coef-
ficient, 0.696; p<0.001) was also concordant with the preious 
study described by Song et al.10 Further detailed study con-
cerning total IgE and SE sensitization should be conducted to 
reveal this unresolved issue.
This study was limited to a small patient group. In addition, 
we could not conduct AHR test in the all enrolled subjects. 
More significant conclusions concerning asthma severity and 
AHR will be achieved if we conduct a larger study. Assessment 
of AHR, when challenged by SE, is likely to reveal the direct as-
sociation between SE and asthma development. Further basic 
study should be followed to reveal the mechanisms how the 
SE sensitization induce AHR and asthma. Although the data 
are not shown due to the insignificance of results, we found 
that total IgE (n=7, 713.8±345.9 kU/mL) in AHR positive pa-
tients tend to be slightly higher than those (n=5, 182.5±132.3 
kU/mL) in AHR negative patients (p=0.244). Further study 
concerning total IgE with AHR might be interesting. This study 
has additional limitation concerning severity parameters. The 
most important severity parameter, medication type and dose 
used in subjects to control symptoms, was not included in this 
study. This is due to the deviated distribution to the medium 
dose inhaled corticosteroid and long-acting β-agonist com-
plex inhaler in almost subjects. 
We have, for the first time, revealed that SE sensitization 
is significantly associated with AHR in common asthma 
patients, despite the small number of subjects studied. This 
result implies that SE sensitization might be associated with 
development of asthma. Further large-scale studies should be 
conducted to harden these results.
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